We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Digital Pathology Technology Set to Transform Medical Diagnosis

By LabMedica International staff writers
Posted on 03 Aug 2023
Print article
Image: The digital pathology scanner significantly improves tests in terms of cost, quality and speed (Photo courtesy of SNP)
Image: The digital pathology scanner significantly improves tests in terms of cost, quality and speed (Photo courtesy of SNP)

Pathologists have historically encountered significant challenges in acquiring sharp, in-focus images without manual intervention. Given that digital pathology images are often thousands of times larger than regular digital photos, automating microscopy for diagnosis from tissue, blood, and other specimen types was considered impossible. However, after a decade of rigorous research by a team of scientists, a transformative breakthrough in medical diagnosis is set to enhance the speed and accuracy of pathology results.

Queensland University of Technology (QUT, Brisbane, Australia) and Sullivan Nicolaides Pathology (SNP, Queensland, Australia) have pioneered an automated microscope scanning and analysis system that has undergone rigorous testing and is now implemented and accredited, ready for global deployment. The system has been shown to significantly improve testing in terms of cost-efficiency, quality, and speed. The cutting-edge digital pathology technology is capable of processing thousands of tests daily and has received accreditation from the National Association of Testing Authorities (NATA).

The system has been shown to enhance the productivity of pathologists and scientists by a factor of 10 or more. It also offers the benefit of seeking second opinions through telepathology and significantly improves record-keeping and access to historical records as there is no need to archive glass slides for years. The system is poised to revolutionize various aspects of healthcare and is already being used by SNP laboratories to enhance diagnostic speed and accuracy.

“Our scientists now use a digitized image often with associated AI instead of being tied to a microscope for many hours,” said SNP Chief Executive Officer Dr. Michael Harrison. “This is the most significant change in the performance of morphological tests for decades.”

“Our active scanner knows what it is scanning and where it should scan, using image analysis and artificial intelligence,” added UQ Professor of AI Brian Lovell. “This greatly increases image quality and reduces file size.”

Related Links:
QUT  
SNP 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.